IMMUNATE SD

Factor VIII concentrate · Baxalta (now part of Shire)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMMUNATE SD, covering 2021-04-29 to 2021-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients [Phase 3]

See pricing